Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
January 17, 2023 09:00 ET
|
Enovis Corporation
Wilmington, DE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the DynaClip Delta™ and DynaClip...
Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 15:10 ET
|
Enovis Corporation
Wilmington, DE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with...
Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
December 01, 2022 09:00 ET
|
Enovis Corporation
Wilmington, DE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has...
Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions
November 17, 2022 08:00 ET
|
Enovis Corporation
Wilmington, DE, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announces the introduction of the DynaNail Helix™, the latest...
Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting
November 10, 2022 10:30 ET
|
Enovis Corporation
Wilmington, DE, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the company’s ARVIS® Augmented Reality...
Enovis Announces Third Quarter 2022 Results
November 02, 2022 06:00 ET
|
Enovis Corporation
Grew sales to $384 million, including 7% organic growth over the prior year quarter, with double-digit growth performance across its Reconstructive segmentReported a net loss of...
Enovis to Participate in Investor Conferences in November
October 28, 2022 15:58 ET
|
Enovis Corporation
Wilmington, DE, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in two...
Enovis to Host Third Quarter 2022 Conference Call on November 2nd
October 13, 2022 09:30 ET
|
Enovis Corporation
Wilmington, DE, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference...
Enovis to Showcase New 510(k) Cleared Foot & Ankle Products at the AOFAS Annual Meeting
September 08, 2022 09:30 ET
|
Enovis Corporation
Wilmington, DE, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase its foot & ankle continuum...
Enovis to Participate in Investor Conferences in September
August 25, 2022 16:01 ET
|
Enovis Corporation
Wilmington, DE, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...